Clinical Trial Update: Evaluation of the Pathobiology of CALR-mutated MPN Cells

View source ↗

Summary

Clinical trial investigating the pathobiology of CALR-mutated myeloproliferative neoplasm cells; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasm

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Myeloproliferative Neoplasm | Status: RECRUITING